We Create Best Products
Cancer of the bladder, the organ that stores and releases urine while voiding, is more common in men than women, by at least 3- 4 times. Like most other tumours of the urinary tract, the incidence of bladder cancer is also rare, under the age of 40 years. That said, like all other cancers, of late bladder cancers affects younger people too without any of the known risk factors.
For a long time, peritoneal cancer was thought to be a very rare disease. This perception may still be true for specific subtypes of peritoneal cancer, such as malignant mesothelioma and pseudomyxoma peritonei (PMP). However, every year hundreds of thousands of patients around the world are diagnosed with peritoneal cancer originating from a primary tumor located .
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells.Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab. These proteins are designed to attach to specific targets found on cancer cells
